GeoVax Receives Massive $300+ Million BARDA Project NextGen Award!

Are we happy, you betcha! We just got back from St Croix where the team from the Beverage Stock Review visited the Mutiny Island Vodka...

GeoVax (GOVX) Research Reports Archive

Research Report Archive Reports from Robert LeBoyer at Noble Capital. Jeffrey Kraws and Karen Goldfarb at Crystal Research. Jason Kolbert at Dawson James Securities. Vernon...

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's approaching $2...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market cap, addressing...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is gone -...

COVID-19 Immunity From mRNA Booster Does Not Last Very Long.

Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to 115 days...

We’re in Tampa for the Kentucky Derby.

GeoVax (GOVX), Sees a Little Volume. Normally, we get a little nervous when one of the companies we follow, shows a spike in either...

Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.

Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever! We're adding Citius Pharma to the Watch...

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class...

GeoVax (GOVX) Launches Vaccine Manufacturing System.

GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA,...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...